A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Advances in Development of New Treatment for Leishmaniasis
2015
BioMed Research International
Leishmaniasis is a neglected infectious disease caused by several different species of protozoan parasites of the genusLeishmania. Current strategies to control this disease are mainly based on chemotherapy. Despite being available for the last 70 years, leishmanial chemotherapy has lack of efficiency, since its route of administration is difficult and it can cause serious side effects, which results in the emergence of resistant cases. The medical-scientific community is facing difficulties to
doi:10.1155/2015/815023
pmid:26078965
pmcid:PMC4442256
fatcat:zryoinstqbdxtn2yf3ysfn7sgm